Biomarker May Predict Immunotherapy Response in Liver Cancer (IMAGE)

Weill Cornell Medicine

Biomarker May Predict Immunotherapy Response in Liver Cancer

Caption

Low NBR1 levels in hepatic stellate cells enhance interferon signaling in human hepatocellular carcinoma. Hepatic stellate cells are labeled in yellow and show reduced NBR1 expression (turquoise), whereas the strong immune response is indicated by STING staining (magenta).

Credit

Moscat and Diaz-Meco labs

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.